SCHEMBL3833545

SCHEMBL3833545

CCOC(=O)c1nc(C)cn1-c1cccc(C#N)c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 5/20 0.53
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 4/20 0.46
ELANE P08246 1/20 0.45
SETD7 Q8WTS6 1/20 0.44
GABRA2 P47869 2/20 0.43
GABRB2 P47870 2/20 0.43
HPGD P15428 2/20 0.43
POLB P06746 1/20 0.43
PDCD1 Q15116 1/20 0.42
CD274 Q9NZQ7 1/20 0.42
TP53 P04637 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
NOTUM Q6P988 1/20 0.41
RECQL P46063 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20028763 0.81 GABRA2 (0.59) KDM4EALDH1A1GABRA2GABRB2HPGD
SCHEMBL3831656 0.77 ALDH1A1 (0.50) GRM5KDM4EALDH1A1ELANEHPGD
SCHEMBL31067538 0.75 KMT2A (0.51) GRM5KDM4EALDH1A1ELANEHPGD
SCHEMBL3833007 0.75 KMT2A (0.51) GRM5KDM4EALDH1A1ELANEHPGD
SCHEMBL4177523 0.75 GABRA2 (0.49) GRM5KDM4EALDH1A1ELANESETD7
SCHEMBL20594850 0.74 NOTUM (0.56) GRM5ALDH1A1ELANEHPGDSMN1; SMN2
SCHEMBL29332789 0.74 NPC1 (0.49) GRM5KDM4EALDH1A1ELANEPOLB
SCHEMBL30309903 0.74 NOTUM (0.56) GRM5ALDH1A1ELANEHPGDSMN1; SMN2
SCHEMBL28743576 0.73 GRM5 (0.47) GRM5NOTUM
SCHEMBL23354648 0.72 GRM5 (0.47) GRM5KDM4EALDH1A1ELANEPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946508-B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2009-09-23 EP disclosed
US-6548512-B1 Pyrazole derivatives such as 1-(3-amidinophenyl)-3-methyl-2-((5-(2'-aminosulfonylphenyl-1-yl)pyrimidin-2 -yl)aminocarbonyl)pyrazole; treating thromboembolic disorders BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-04-15 US disclosed
US-6020357-A CARDIOVASCULAR DISORDERS; ANTCOAGULANTS DUPONT PHARMACEUTICALS COMPANY (US) 2000-02-01 US disclosed
EP-0946508-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
WO-1998028269-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed